FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022052685> ?p ?o ?g. }

• W2022052685 endingPage "30" @default.
• W2022052685 startingPage "22" @default.
• W2022052685 abstract "The aims were to investigate the effect of intravenous infusions of the tumor necrosis factor-alpha (TNF-alpha) antibody infliximab on symptoms and signs of temporomandibular joint (TMJ) involvement in relation to effects on synovial fluid and plasma proinflammatory TNF-alpha, interleukin-1beta (IL-1beta) and interleukin-6 as well as antiinflam matory soluble TNF receptor II (TNF-sRII), interleukin-1 receptor antagonist (IL-1ra), soluble IL-1 receptor II (IL-1sRII) and interleukin-10 (IL-10) in patients with active rheumatoid arthritis (RA). Nineteen patients with TMJ involvement taking methotrexate were included in the study. TMJ and general joint pain intensity as well as pain on mandibular movements, tenderness to digital palpation, pressure pain threshold and maximum mouth-opening capacity were assessed in a clinical examination. The effect of infliximab was assessed after 2 and 14 or 22 weeks. TMJ synovial fluid and venous blood were collected for cytokine analysis at all occasions while determination of erythrocyte sedimentation rate and C-reactive protein were performed at baseline and at long-term follow-up only. Reduction of TMJ pain was associated with raised levels of synovial fluid TNF-sRII and IL-1sRII as well as raised plasma levels of IL-1ra and IL-10. Decreased erythrocyte sedimentation rate was associated with decreased tenderness to digital palpation. Reduced general joint pain intensity was associated with reduced plasma levels of IL-6 and C-reactive protein. In conclusion, systemic treatment with a combination of infliximab and methotrexate reduces TMJ pain in RA in association with an increase in anti-inflammatory cytokines and receptors in synovial fluid and plasma." @default.
• W2022052685 created "2016-06-24" @default.
• W2022052685 creator A5031739976 @default.
• W2022052685 creator A5055169457 @default.
• W2022052685 creator A5070713558 @default.
• W2022052685 creator A5074496478 @default.
• W2022052685 creator A5075211876 @default.
• W2022052685 creator A5085603352 @default.
• W2022052685 date "2005-01-01" @default.
• W2022052685 modified "2023-10-01" @default.
• W2022052685 title "Reduction of Temporomandibular Joint Pain after Treatment with a Combination of Methotrexate and Infliximab Is Associated with Changes in Synovial Fluid and Plasma Cytokines in Rheumatoid Arthritis" @default.
• W2022052685 cites W1969887614 @default.
• W2022052685 cites W1978515480 @default.
• W2022052685 cites W1985763670 @default.
• W2022052685 cites W1996472975 @default.
• W2022052685 cites W1998821686 @default.
• W2022052685 cites W2001181685 @default.
• W2022052685 cites W2002052859 @default.
• W2022052685 cites W2035445024 @default.
• W2022052685 cites W2052914753 @default.
• W2022052685 cites W2063844486 @default.
• W2022052685 cites W2065506072 @default.
• W2022052685 cites W2075046655 @default.
• W2022052685 cites W2082534989 @default.
• W2022052685 cites W2087050793 @default.
• W2022052685 cites W2139665761 @default.
• W2022052685 cites W2142273705 @default.
• W2022052685 cites W2147358290 @default.
• W2022052685 cites W2152348310 @default.
• W2022052685 cites W2319957449 @default.
• W2022052685 doi "https://doi.org/10.1159/000086195" @default.
• W2022052685 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16088130" @default.
• W2022052685 hasPublicationYear "2005" @default.
• W2022052685 type Work @default.
• W2022052685 sameAs 2022052685 @default.
• W2022052685 citedByCount "35" @default.
• W2022052685 countsByYear W20220526852012 @default.
• W2022052685 countsByYear W20220526852013 @default.
• W2022052685 countsByYear W20220526852014 @default.
• W2022052685 countsByYear W20220526852015 @default.
• W2022052685 countsByYear W20220526852017 @default.
• W2022052685 countsByYear W20220526852018 @default.
• W2022052685 countsByYear W20220526852019 @default.
• W2022052685 countsByYear W20220526852021 @default.
• W2022052685 countsByYear W20220526852022 @default.
• W2022052685 countsByYear W20220526852023 @default.
• W2022052685 crossrefType "journal-article" @default.
• W2022052685 hasAuthorship W2022052685A5031739976 @default.
• W2022052685 hasAuthorship W2022052685A5055169457 @default.
• W2022052685 hasAuthorship W2022052685A5070713558 @default.
• W2022052685 hasAuthorship W2022052685A5074496478 @default.
• W2022052685 hasAuthorship W2022052685A5075211876 @default.
• W2022052685 hasAuthorship W2022052685A5085603352 @default.
• W2022052685 hasConcept C126322002 @default.
• W2022052685 hasConcept C142724271 @default.
• W2022052685 hasConcept C164027704 @default.
• W2022052685 hasConcept C17991360 @default.
• W2022052685 hasConcept C204787440 @default.
• W2022052685 hasConcept C2776164576 @default.
• W2022052685 hasConcept C2776268809 @default.
• W2022052685 hasConcept C2776914184 @default.
• W2022052685 hasConcept C2777077863 @default.
• W2022052685 hasConcept C2777138892 @default.
• W2022052685 hasConcept C2777575956 @default.
• W2022052685 hasConcept C2778143017 @default.
• W2022052685 hasConcept C2780202543 @default.
• W2022052685 hasConcept C2781059491 @default.
• W2022052685 hasConcept C71924100 @default.
• W2022052685 hasConcept C90924648 @default.
• W2022052685 hasConceptScore W2022052685C126322002 @default.
• W2022052685 hasConceptScore W2022052685C142724271 @default.
• W2022052685 hasConceptScore W2022052685C164027704 @default.
• W2022052685 hasConceptScore W2022052685C17991360 @default.
• W2022052685 hasConceptScore W2022052685C204787440 @default.
• W2022052685 hasConceptScore W2022052685C2776164576 @default.
• W2022052685 hasConceptScore W2022052685C2776268809 @default.
• W2022052685 hasConceptScore W2022052685C2776914184 @default.
• W2022052685 hasConceptScore W2022052685C2777077863 @default.
• W2022052685 hasConceptScore W2022052685C2777138892 @default.
• W2022052685 hasConceptScore W2022052685C2777575956 @default.
• W2022052685 hasConceptScore W2022052685C2778143017 @default.
• W2022052685 hasConceptScore W2022052685C2780202543 @default.
• W2022052685 hasConceptScore W2022052685C2781059491 @default.
• W2022052685 hasConceptScore W2022052685C71924100 @default.
• W2022052685 hasConceptScore W2022052685C90924648 @default.
• W2022052685 hasIssue "1" @default.
• W2022052685 hasLocation W20220526851 @default.
• W2022052685 hasLocation W20220526852 @default.
• W2022052685 hasOpenAccess W2022052685 @default.
• W2022052685 hasPrimaryLocation W20220526851 @default.
• W2022052685 hasRelatedWork W19323031 @default.
• W2022052685 hasRelatedWork W2059515661 @default.
• W2022052685 hasRelatedWork W2083125534 @default.
• W2022052685 hasRelatedWork W2137485620 @default.
• W2022052685 hasRelatedWork W2146517830 @default.
• W2022052685 hasRelatedWork W2319957449 @default.
• W2022052685 hasRelatedWork W2376796343 @default.
• W2022052685 hasRelatedWork W2379436644 @default.

• next